Sanara MedTech Inc. SMTI Deferred Tax Assets, Valuation Allowance
Deferred Tax Assets, Valuation Allowance at other companies
Other financials
Where this comes from
Reported directly by Sanara MedTech Inc. in its filing.
Tagged under the XBRL concept us-gaap:DeferredTaxAssetsValuationAllowance.
The official record: Sanara MedTech Inc.’s 10-K, filed March 24, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sanara MedTech Inc.'s deferred tax assets, valuation allowance.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sanara MedTech Inc.'s deferred tax assets, valuation allowance?
- Sanara MedTech Inc. (SMTI) reported deferred tax assets, valuation allowance of $20.91M in Q4 2025.
- How has Sanara MedTech Inc.'s deferred tax assets, valuation allowance changed year-over-year?
- Sanara MedTech Inc.'s deferred tax assets, valuation allowance increased by 66.8% year-over-year, from $12.53M to $20.91M.
- What is the long-term trend for Sanara MedTech Inc.'s deferred tax assets, valuation allowance?
- Over 5 years (2020 to 2025), Sanara MedTech Inc.'s deferred tax assets, valuation allowance has grown at a 43.5% compound annual growth rate (CAGR), from $3.43M to $20.91M.